StocktradeC

ABBV long setup

Pembelian
NYSE:ABBV   AbbVie Inc.
ABBV’s innovation outlook is trending up based on a current score of 70 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is positive. ABBV is an Outperformer in terms of sustainability. It is most exposed to AstraZeneca PLC as its supplier. Over the past 4 quarters ABBV beat earnings estimates 3 times and it pays dividend higher than its peers.
For more analysis and articles visit our website.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.